Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Thalassemic patients often suffer from iron overload due to frequent blood transfusion. Oral iron chelators reduce iron overload in transfusion dependent patients. The aim of this study is to compare the efficacy and safety of osveral and desferal in transfusional iron overload patients with β-Thalassemia and intermediate Thalassemia in Bandarabbas.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hormozgan University of Medical Sciences
• Treatments: Deferasirox; Deferoxamine

Criteria

Inclusion Criteria:

• Confirmed intermedia or major thalassemia

• More then 2 years old

• Serum Ferritin level > 1000

• Normal Creatinine and Complete Blood Count (CBC)

Exclusion Criteria:

• HCV, HBV or HIV positive patients